A Gazzin, F Fornari, M Niceta, C Leoni… - European Journal of …, 2024 - nature.com
Hypertrophic cardiomyopathy (HCM) is the major contributor to morbidity and mortality in Noonan syndrome (NS). Gain-of-function variants in RAF1 are associated with high …
Childhood-onset myocardial hypertrophy and cardiomyopathic changes are associated with significant morbidity and mortality in early life, particularly in patients with Noonan syndrome …
Congenital heart diseases (CHDs), which affect the structure and function of the heart or great vessels, are the most common type of birth defect and the leading cause of pediatric …
Human induced pluripotent stem cells (hiPSCs) have emerged as powerful tools for disease modeling and drug discovery. In this work, we established a novel hiPSC-derived 3D …
IL Gallán Farina, JI Labarta Aizpún - zaguan.unizar.es
El síndrome de Noonan (SN) es un trastorno genético del desarrollo, con gran variabilidad clínica y etiológica, que afecta a 1 de cada 1000-2500 nacidos vivos. Se caracteriza por …
El síndrome de Noonan (SN; Mendelian Inheritance in Man reference 163950) fue descrito por la cardióloga pediátrica Jacqueline Anne Noonan en 1968 [1], basándose en la …